Skip to playerSkip to main contentSkip to footer
  • 6/12/2024
Jim Cramer has expressed his confidence in Eli Lilly, LLY, citing the company’s diverse drug portfolio and the recent endorsement of its Alzheimer’s treatment by FDA advisors.

Category

🗞
News

Recommended